Found: 10
Select item for more details and to access through your institution.
Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Progressive Demyelination in the Presence of Serum Myelin Oligodrndrocyte Glycoprotein-IgG: A Case Report.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Positron emission tomography: a false negative result in cystic encephalic mestastases from a small cell bronchial carcinoma.
- Published in:
- Clinical & Translational Oncology, 2006, v. 8, n. 8, p. 618, doi. 10.1007/s12094-006-0070-4
- By:
- Publication type:
- Article
Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0230846
- By:
- Publication type:
- Article
Episodic migraine and chest pain as the first manifestation of small cell lung carcinoma.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 8, p. 1346, doi. 10.1002/ccr3.2618
- By:
- Publication type:
- Article
Novel P397S MAPT variant associated with late onset and slow progressive frontotemporal dementia.
- Published in:
- Annals of Clinical & Translational Neurology, 2019, v. 6, n. 8, p. 1559, doi. 10.1002/acn3.50844
- By:
- Publication type:
- Article
Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 7, p. 3676, doi. 10.1007/s00415-022-10989-0
- By:
- Publication type:
- Article
Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required.
- Published in:
- Multiple Sclerosis (13524585), 2009, v. 15, n. 11, p. 1303, doi. 10.1177/1352458509107015
- By:
- Publication type:
- Article